drugset / Trial / NCT03546400

Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.

NCT03546400 ↗

Phase 4 Withdrawn Pfizer
NaSingle-groupOpen-labelTreatment

Summary

2-week open-label safety, tolerability and pharmacokinetic study of methylphenidate HCl ERCT in 4-5 year old children with ADHD.

Timeline

Start
2018-09-25
Primary completion
2020-12-03
Completion
2020-12-03

Outcome

Outcome not reported

Stopped (Enrollment): “The study was cancelled prior to the enrollment of any participants.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule — —